Welcome to Medications.com

Dr. Reddy's Rough Quarter - Motley Fool

... quarter included revenues from authorized generics, as well as from exclusive marketing of its generic version of GlaxoSmithKline's (NYSE: GSK) Zofran. ...

http://www.fool.com/investing/val... | Posted: Mon Jan 28 16:04:43 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea